The use of progesterone administered intravaginally and pregnant mare serum gonadotrophin given by injection in controlled breeding programs in beef and dairy cattle.
Five experiments involving 1,244 cows and heifers were carried out to investigate the factors which might influence the calving performance to fixed-time artificial insemination following intravaginal administration of progesterone (PRID) and intramuscular injection of pregnant mare serum gonadotrophin (PMSG). Factors examined were duration of PRID treatment, time of treatment after calving, time and dose PMSG and lactational status. Experiments 1, 2 and 3 were carried out on milked Friesian cows, experiment 4 on Friesian heifers and experiment 5 on suckled and dry Herefords. All cows were inseminated once with frozen/thawed semen 54 to 58 h or 46 to 50 h after completion of PRID treatment. Overall there was a progressive increase in calving rates with an increase in the duration of treatment from 12 to 14 to 16 days but there was little or no effect of time after calving (4 v 7 weeks) at which treatment was commenced. The poorer calving performance of cows treated for 12 to 14 days was associated with relatively high peripheral levels of plasma progesterone at the time of the PRID removal, suggesting the presence at the end of treatment of residual secretory luteal tissue. There was an effect on calving performance of PMSG given at the time of PRID removal but its effect varied according to the duration of PRID treatment. After 12 days treatments (experiments 1 and 5) PMSG had little effect, whereas after 14 days treatments, 0, 500 and 750 IU PMSG gave calving rates of 27%, 40% and 46% in experiment 2 and 5%, 24% and 38% in experiment 5.(ABSTRACT TRUNCATED AT 250 WORDS)
D000822:Animal Husbandry; D000818:Animals; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004958:Estradiol / Q000008:administration & dosage; D004971:Estrus / Q000187:drug effects; D005260:Female; D006064:Gonadotropins, Equine / Q000008:administration & dosage*; D007273:Injections, Intramuscular; D007315:Insemination, Artificial / Q000662:veterinary; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D011374:Progesterone / Q000008:administration & dosage* / Q000097:blood; D014621:Vagina / Q000187:drug effects
D006064:Gonadotropins, Equine; D011374:Progesterone; D004958:Estradiol